Clinical Trial Results:
A multi-center, randomized, open-label, prospective bridging, parallel dosefinding trial comparing efficacy, safety and pharmacokinetics of 4 doses of Org 25969 and placebo administered at reappearance of T2 after rocuronium or vecuronium in Japanese and Caucasian subjects. Part B: Caucasian subjects.
Summary
|
|
EudraCT number |
2005-001133-15 |
Trial protocol |
SE BE DE |
Global completion date |
31 Aug 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Aug 2016
|
First version publication date |
03 Aug 2016
|
Other versions |
|
Summary report(s) |
publicly available results synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.